axitinib 5 MG Oral Tablet

RxCUI
1243012
RxNorm name
axitinib 5 MG Oral Tablet
Display name
Axitinib (Oral Pill)
Full name
axitinib 5 MG Oral Tablet
Term type
SCD
Status
Active
Strength
5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-19 15:40:52

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032012
Active start
032012
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
axitinib5 MG / 1 EACHaxitinibaxitinib

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
axitinib1242999

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRaxitinib 5 MG Oral Tablet1NAMES
RxNorm Nameaxitinib 5 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI12430121CODES
MMSL_CODECD273401CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INLYTAAXITINIBU.S. Pharmaceuticals8a903e31-936e-4ed7-8a59-59f32374f3382026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 1243012
INLYTAAXITINIBPfizer Laboratories Div Pfizer Inc84137882-e000-47da-bd5b-fa76ab3c76f92025-02-19Warnings, Adverse reactionsExact identifier
rxcui: 1243012

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
84137882-e000-47da-bd5b-fa76ab3c76f9axitinib 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [SCD]224These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 201220250219
8a903e31-936e-4ed7-8a59-59f32374f338axitinib 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [SCD]212These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 201220260312

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01EKVascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitorsATC1-4axitinib
FDASPLN0000175605Kinase InhibitorEPChas_epcaxitinib
FDASPLN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moaaxitinib
MEDRTD000077784AxitinibCHEMhas_ingredientaxitinib
MEDRTD002292Carcinoma, Renal CellDISEASEmay_treataxitinib
MEDRTN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moaaxitinib
MEDRTN0000175672Cellular Proliferation AlterationPEhas_peaxitinib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH5 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESSNOMEDCT765651007
CODESVUID4031305
NAMESPrescribable Synonymaxitinib 5 MG Oral Tablet
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File